Todd Harris, President and CEO at Tyra Biosciences, Inc. (TYRA), sold 200,000 shares at $16.97 ($3.3M) on 2024-02-05, disclosed to the SEC on 2024-02-06.
Scheduled sale ($3.3M) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.45 | 78,996 | $1.3M | 39.2% |
| 2 | $16.45 | 78,996 | $1.3M | 39.2% |
| 3 | $17.04 | 7,187 | $122K | 3.7% |
| 4 | $17.04 | 7,187 | $122K | 3.7% |
| 5 | $16.97 | 13,817 | $234K | 7.1% |
| 6 | $16.97 | 13,817 |
| $234K |
| 7.1% |
| Total | $16.56 avg | 200,000 | $3.3M | 100% |
| Filing → |
| TYRA | SELL | 2024-10-02 | $12K | — | Filing → |
| TYRA | SELL | 2024-09-25 | $527K | — | Filing → |
| TYRA | SELL | 2024-09-20 | $704K | — | Filing → |